Predicting liver SBRT eligibility and plan quality for VMAT and 4π plans
Creators
- 1. Department of Radiation Oncology, University of California, 200 Medical Plaza, Suite B265, Los Angeles, CA 90095 (United States)
- 2. Translational Medicine Institute, Zhejiang University, Zhejiang (China)
Description
It is useful to predict planned dosimetry and determine the eligibility of a liver cancer patient for SBRT treatment using knowledge based planning (KBP). We compare the predictive accuracy using the overlap volume histogram (OVH) and statistical voxel dose learning (SVDL) KBP prediction models for coplanar VMAT to non-coplanar 4π radiotherapy plans. In this study, 21 liver SBRT cases were selected, which were initially treated using coplanar VMAT plans. They were then re-planned using 4π IMRT plans with 20 inversely optimized non-coplanar beams. OVH was calculated by expanding the planning target volume (PTV) and then plotting the percent overlap volume v with the liver vs. rv, the expansion distance. SVDL calculated the distance to the PTV for all liver voxels and bins the voxels of the same distance. Their dose information is approximated by either taking the median or using a skew-normal or non-parametric fit, which was then applied to voxels of unknown dose for each patient in a leave-one-out test. The liver volume receiving less than 15 Gy (V<ââ'¬‹sub><15Gy<ââ'¬‹/sub>), DVHs, and 3D dose distributions were predicted and compared between the prediction models and planning methods. On average, V<ââ'¬‹sub><15Gy<ââ'¬‹/sub> was predicted within 5%. SVDL was more accurate than OVH and able to predict DVH and 3D dose distributions. Median SVDL yielded predictive errors similar or lower than the fitting methods and is more computationally efficient. Prediction of the 4π dose was more accurate compared to VMAT for all prediction methods, with significant (p < 0.05) results except for OVH predicting liver V<ââ'¬‹sub><15Gy<ââ'¬‹/sub> (p = 0.063). In addition to evaluating plan quality, KBP is useful to automatically determine the patient eligibility for liver SBRT and quantify the dosimetric gains from non-coplanar 4π plans. The two here analyzed dose prediction methods performed more accurately for the 4π plans than VMAT.
Availability note (English)
Available from http://dx.doi.org/10.1186/s13014-017-0806-z; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404690Additional details
Identifiers
Publishing Information
- Journal Title
- Radiation Oncology (Online)
- Journal Volume
- 12
- Journal Page Range
- vp.
- ISSN
- 1748-717X
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49082378
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- GY RANGE 10-100; LIVER; PATIENTS; RADIATION DOSE DISTRIBUTIONS; RADIATION DOSES; RADIOTHERAPY
- Descriptors DEC
- ABSORBED DOSE RANGE; BODY; DIGESTIVE SYSTEM; DOSES; GLANDS; GY RANGE; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIATION DOSE RANGES; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) The Author(s). 2017
- Notes
- PMCID: PMC5404690; PMID: 28438215; PUBLISHER-ID: 806; OAI: oai:pubmedcentral.nih.gov:5404690